Testing a new progesterone tablet for luteal phase issues
Part of Women’s health & pregnancy clinical trials.
This trial tests a new progesterone tablet (Callavid) to see if it is safe and easy to use for women with a short or weak luteal phase (the time after ovulation). It may help support early pregnancy and reduce the risk of miscarriage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 45 years old.
- You have had at least one miscarriage in the past.
- You have a condition called luteal phase insufficiency, which may cause spotting before your period, a very short time between ovulation and your period, or other symptoms of low progesterone.
- You are not currently pregnant or breastfeeding.
- You have no allergies to progesterone or similar hormone medications, and no history of conditions like breast cancer that prevent hormone treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving extra progesterone injections after an embryo transfer can improve pregnancy outcomes for women who have low progesterone levels. It may help support the pregnancy in its early stages.
This study tests how hormone levels (progesterone) change day to day in the lining of the uterus (endometrium) during an embryo transfer in a medicated cycle. The goal is to better time the transfer and improve success rates.
This study looks at how progesterone levels change in the early part of the luteal phase (after ovulation) when ovulation is triggered by an hCG injection in a natural cycle. It may help women undergoing routine ovulation induction understand how their body responds.
This study compares two ways of giving progesterone to postmenopausal women. It aims to see how the body absorbs each form, which may help guide future treatment options.
This trial tests a new birth control pill with a lower dose of estrogen and a different type of progestin. It aims to see how well it prevents pregnancy and if it's safe for women to use.
This trial tests a new contraceptive patch to see if it can prevent ovulation (the release of an egg). If you are a healthy woman looking for a non-hormonal birth control option, this study may be a good fit.
Hear when a new Luteal Phase Insuffiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.